Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Mallinckrodt
Chinese Patent Office
Federal Trade Commission
Chubb
Fuji
Julphar
Cipla

Generated: December 11, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR METHAMPHETAMINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Methamphetamine Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00000241 Flupenthixol Decanoate in Methamphetamine Smoking - 1 Completed Friends Research Institute, Inc. Phase 2 The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.
NCT00000241 Flupenthixol Decanoate in Methamphetamine Smoking - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.
NCT00000321 Methamphetamine Abuse Treatment in Patients With AIDS - 1 Completed Friends Research Institute, Inc. Phase 4 The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.
NCT00000321 Methamphetamine Abuse Treatment in Patients With AIDS - 1 Completed National Institute on Drug Abuse (NIDA) Phase 4 The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.
NCT00000340 Pemoline in the Treatment of Stimulant Dependence - 5 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to assess the efficacy of pemoline in treating cocaine and/or methamphetamine dependent adults with comorbid Adult Attention Deficit Hyperactivity Disorder (ADHD).
NCT00033072 Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1 Unknown status National Institute on Drug Abuse (NIDA) Phase 1 The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral selegiline.
NCT00040040 Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1 Unknown status University of California, Los Angeles Phase 1 The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Methamphetamine Hydrochloride

Condition Name

Condition Name for Methamphetamine Hydrochloride
Intervention Trials
Methamphetamine Dependence 43
Substance Abuse 16
Methamphetamine Abuse 16
Amphetamine-Related Disorders 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Methamphetamine Hydrochloride
Intervention Trials
Substance-Related Disorders 27
Amphetamine-Related Disorders 19
Disease 6
HIV Infections 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Methamphetamine Hydrochloride

Trials by Country

Trials by Country for Methamphetamine Hydrochloride
Location Trials
United States 133
China 4
Malaysia 3
Thailand 2
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Methamphetamine Hydrochloride
Location Trials
California 49
Texas 14
Arkansas 8
Utah 7
New York 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Methamphetamine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Methamphetamine Hydrochloride
Clinical Trial Phase Trials
Phase 4 14
Phase 3 6
Phase 2/Phase 3 1
[disabled in preview] 83
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Methamphetamine Hydrochloride
Clinical Trial Phase Trials
Completed 63
Recruiting 14
Unknown status 11
[disabled in preview] 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Methamphetamine Hydrochloride

Sponsor Name

Sponsor Name for Methamphetamine Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 58
University of California, Los Angeles 20
Baylor College of Medicine 8
[disabled in preview] 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Methamphetamine Hydrochloride
Sponsor Trials
Other 118
NIH 61
Industry 11
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Fish and Richardson
Johnson and Johnson
Farmers Insurance
QuintilesIMS
Federal Trade Commission
Cantor Fitzgerald
Fuji
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.